Wednesday, 08 February 2017 08:24

Recall Of Three Brands Of Fleming Pharmaceutical Products

Rate this item
(4 votes)

The attention of the National Agency for Food and Drug Administration and Control (NAFDAC) has been drawn to the recall of three brands of Fleming pharmaceutical products on November 14, 2016 by the Hong Kong Department of Health (DH) over misinformation of the package label instruction which do not match with the registered version, thereby rendering the products unregistered and unsafe for human consumption. The products which contained amoxicillin and clavulanic acid were supplied by Hong Kong-based Medreich Pharmaceutical franchise, Medreich Far East Limited.

THE RECALLED PRODUCT DETAILS: 

PRODUCT NAME REGISTRATION NUMBER
Fleming Tablets 1g HK- 52242
Fleming for oral suspension 457mg/5m HK- 56072
Fleming for suspension 228.5mg/5ml HK- 56069

HEALTHCARE PROVIDER’S ACTION

  • Healthcare providers and patients in possession of these affected products should stop using them.
  • Healthcare providers and patients are encouraged to report adverse events associated with the use of these products to the nearest NAFDAC office, NAFDAC PRASCOR (20543 TOLL FREE from all networks) or via This email address is being protected from spambots. You need JavaScript enabled to view it.

NAFDAC........Safeguarding the Health of the Nation!!!

Read 2862 times Last modified on Monday, 13 February 2017 15:37

CORPORATE LINKS